NIH urged to cap profits made on publicly funded research

Colin Macilwain

Nature, 2000, vol. 406, issue 6791, 5-5

Abstract: Washington The US National Institutes of Health has become caught in the cross-fire over one of the most contentious issues in the US presidential campaign: the high cost of therapeutic drugs.

Date: 2000
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/35017714 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:406:y:2000:i:6791:d:10.1038_35017714

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35017714

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().